Searched for: school:SOM
Department/Unit:Child and Adolescent Psychiatry
The Transition of Academic Mental Health Clinics to Telehealth During the COVID-19 Pandemic
Folk, Johanna B; Schiel, Marissa A; Oblath, Rachel; Feuer, Vera; Sharma, Aditi; Khan, Shabana; Doan, Bridget; Kulkarni, Chetana; Ramtekkar, Ujjwal; Hawks, Jessica; Fornari, Victor; Fortuna, Lisa R; Myers, Kathleen
OBJECTIVE:A consortium of eight academic child and adolescent psychiatry programs in the United States and Canada examined their pivot from in-person, clinic-based services to home-based telehealth during the COVID-19 pandemic. The aims were to document the transition across diverse sites and present recommendations for future telehealth service planning. METHOD/METHODS:Consortium sites completed a Qualtrics survey assessing site characteristics, telehealth practices, service utilization, and barriers to and facilitators of telehealth service delivery prior to (pre) and during the early stages of (post) the COVID-19 pandemic. The design is descriptive. RESULTS:All sites pivoted from in-person services to home-based telehealth within two weeks. Some sites experienced delays in conducting new intakes and most experienced delays establishing tele-group therapy. No-show rates and utilization of telephony versus videoconferencing varied by site. Changes in telehealth practices (e.g., documentation requirements, safety protocols) and perceived barriers to telehealth service delivery (e.g., regulatory limitations, inability to bill) occurred pre/post-COVID-19. CONCLUSION/CONCLUSIONS:A rapid pivot from in-person services to home-based telehealth occurred at eight diverse academic programs in the context of a global crisis. To promote ongoing use of home-based telehealth during future crises and usual care, academic programs should continue documenting the successes and barriers to telehealth practice to promote equitable and sustainable telehealth service delivery in the future.
PMID: 34119633
ISSN: 1527-5418
CID: 4911162
An Individual Participant Data Meta-analysis: Behavioral Treatments for Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
Groenman, Annabeth P; Hornstra, Rianne; Hoekstra, Pieter J; Steenhuis, Laura; Aghebati, Asma; Boyer, Bianca E; Buitelaar, Jan K; Chronis-Tuscano, Andrea; Daley, David; Dehkordian, Parisa; Dvorsky, Melissa; Franke, Nike; DuPaul, George J; Gershy, Naama; Harvey, Elizabeth; Hennig, Timo; Herbert, Sharonne; Langberg, Joshua; Mautone, Jennifer A; Mikami, Amori Yee; Pfiffner, Linda J; Power, Thomas J; Reijneveld, Sijmen A; Schramm, Saytam Antonio; Schweitzer, Julie B; Sibley, Margaret H; Sonuga-Barke, Edmund; Thompson, Catharine; Thompson, Margaret; Webster-Stratton, Carolyn; Xie, Yuhuan; Luman, Marjolein; van der Oord, Saskia; van den Hoofdakker, Barbara J
OBJECTIVE:Behavioral interventions are well established treatments for children with attention-deficit/hyperactivity disorder (ADHD). However, insight into moderators of treatment outcome is limited. METHOD/METHODS:We conducted an individual participant data meta-analysis [IPDMA], including data of randomized controlled behavioral intervention trials for individuals with ADHD<18 years. Outcomes were symptoms of ADHD, oppositional defiant disorder (ODD), and conduct disorder (CD) and impairment. Moderators investigated were symptoms and impairment severity, medication use, age, IQ, sex, socioeconomic status, and single parenthood. RESULTS:For raters most proximal to treatment, small to medium sized effects of behavioral interventions were found for symptoms of ADHD, inattention, hyperactivity/impulsivity (HI), ODD and CD, and impairment. Blinded outcomes were only available for small preschool subsamples and limited measures. CD symptoms and/or diagnosis moderated outcome on ADHD, HI, ODD, and CD symptoms. Single parenthood moderated ODD outcome, ADHD severity moderated impairment outcome. Higher baseline CD or ADHD symptoms, a CD diagnosis, and single parenthood were related to worsening of symptoms in the untreated, but not in the treated group, indicating a protective rather than an ameliorative effect of behavioral interventions for these children. CONCLUSION/CONCLUSIONS:Behavioral treatments are effective for reducing ADHD symptoms, behavioral problems, and impairment as reported by raters most proximal to treatment. Those with severe CD or ADHD symptoms, a CD diagnosis, or single parents, should be prioritized for treatment, as they may evidence worsening of symptoms in the absence of intervention.
PMID: 33932495
ISSN: 1527-5418
CID: 4865792
Association between autism spectrum disorder and inflammatory bowel disease: A systematic review and meta-analysis
Kim, Jong Yeob; Choi, Min Je; Ha, Sungji; Hwang, Jimin; Koyanagi, Ai; Dragioti, Elena; Radua, Joaquim; Smith, Lee; Jacob, Louis; de Pablo, Gonzalo Salazar; Lee, Seung Won; Yon, Dong Keon; Thompson, Trevor; Cortese, Samuele; Lollo, Gianluca; Liang, Chih-Sung; Chu, Che-Sheng; Fusar-Poli, Paolo; Cheon, Keun-Ah; Shin, Jae Il; Solmi, Marco
Children with autism spectrum disorder (ASD) are frequently diagnosed with co-occurring medical conditions including inflammatory bowel disease (IBD). To investigate the association, we conducted a systematic review registered in PROSPERO (ID:CRD42021236263) with a random-effects meta-analysis. We searched PubMed, Embase, and PsycInfo (last search on January 25, 2021), and manually searched relevant publications. We included observational studies measuring the association between ASD and IBD. The primary outcome was the association (odds ratio, OR) between ASD and later development of IBD. Sensitivity analyses were conducted by quality, confounding adjustment, and study design. We performed meta-regression analyses and assessed heterogeneity, publication bias, and quality of studies with the Newcastle-Ottawa Scale. Overall, we included six studies consisting of eight datasets, including over 11 million participants. We found that ASD was significantly associated with subsequent incident IBD (any IBD, OR = 1.66, 95% confidence interval[CI] = 1.25-2.21, p < 0.001; ulcerative colitis, OR = 1.91, 95%CI = 1.41-2.6, p < 0.001; Crohn's disease, OR = 1.47, 95%CI = 1.15-1.88, p = 0.002). ASD and IBD were also associated regardless of temporal sequence of diagnosis (any IBD, OR = 1.57, 95%CI = 1.28-1.93, p < 0.001; ulcerative colitis, OR = 1.7, 95%CI = 1.36-2.12, p < 0.001; Crohn's disease, OR = 1.37, 95%CI = 1.12-1.69, p = 0.003). Sensitivity analyses confirmed the findings of the main analysis. Meta-regression did not identify any significant moderators. Publication bias was not detected. Quality was high in four datasets and medium in four. In conclusion, our findings highlight the need to screen for IBD in individuals with ASD, and future research should identify who, among those with ASD, has the highest risk of IBD, and elucidate the shared biological mechanisms between ASD and IBD.
PMID: 34939353
ISSN: 1939-3806
CID: 5100012
Autism in a Child With X-linked Agammaglobulinemia [Case Report]
Bied, Adam; Njuguna, Susan; Satodiya, Ritvij
A growing evidence base has implicated immune dysfunction in the etiology of some cases of autism spectrum disorder. The precise relationship between immune disorders and autism spectrum disorder remains unclear. Herein we report a 14-year-old-male with agammaglobulinemia, who was diagnosed with autism spectrum disorder, and who has received exogenous immunoglobulins regularly for most of his life. This case study supports current theories implicating antibody deficiencies in some individuals with an autism spectrum disorder. Our case will add to the growing literature of understanding the connection between immune deficiencies in the pathogenesis of autism.
PMCID:8904032
PMID: 35282518
ISSN: 2168-8184
CID: 5220662
Altered physical pain processing in different psychiatric conditions
Kim, Diane J; Mirmina, Julianne; Narine, Serah; Wachtel, Jonathan; Carbajal, Jessica M; Fox, Helen; Cáceda, Ricardo
Several reports indicate either increased or decreased pain sensitivity associated with psychiatric disorders. Chronic pain is highly prevalent in many of these conditions. We reviewed the literature regarding experimental pain sensitivity in patients with major depression, bipolar disorder, posttraumatic stress disorder (PTSD), generalized anxiety disorder, panic disorder, obsessive-compulsive disorder and schizophrenia. Electronic searches were performed to identify studies comparing experimental pain in patients with these conditions and controls. Across 31 depression studies, reduced pain threshold was noted except for ischemic stimuli, where increased pain tolerance and elevated sensitivity to ischemic pain was observed. A more pervasive pattern of low pain sensitivity was found across 20 schizophrenia studies. The majority of PTSD studies (n = 20) showed no significant differences compared with controls. The limited number of bipolar disorder (n = 4) and anxiety (n = 9) studies precluded identification of clear trends. Wide data variability was observed. Awareness of psychiatric patients' pain perception abnormalities is needed for active screening and addressing physical comorbidities, in order to enhance quality of life, life expectancy and mental health.
PMID: 34952034
ISSN: 1873-7528
CID: 5644122
Combined Topiramate and Metformin Pharmacotherapy for Second-Generation Antipsychotic-Induced Weight Gain in Pediatric Bipolar Disorder and Aggression
Nagy, Lauren R; Rice, Timothy; Coffey, Barbara J
PMID: 35166568
ISSN: 1557-8992
CID: 5671232
Robust chronic convulsive seizures, high frequency oscillations, and human seizure onset patterns in an intrahippocampal kainic acid model in mice
Lisgaras, Christos Panagiotis; Scharfman, Helen E
Intrahippocampal kainic acid (IHKA) has been widely implemented to simulate temporal lobe epilepsy (TLE), but evidence of robust seizures is usually limited. To resolve this problem, we slightly modified previous methods and show robust seizures are common and frequent in both male and female mice. We employed continuous wideband video-EEG monitoring from 4 recording sites to best demonstrate the seizures. We found many more convulsive seizures than most studies have reported. Mortality was low. Analysis of convulsive seizures at 2-4 and 10-12 wks post-IHKA showed a robust frequency (2-4 per day on average) and duration (typically 20-30 s) at each time. Comparison of the two timepoints showed that seizure burden became more severe in approximately 50% of the animals. We show that almost all convulsive seizures could be characterized as either low-voltage fast or hypersynchronous onset seizures, which has not been reported in a mouse model of epilepsy and is important because these seizure types are found in humans. In addition, we report that high frequency oscillations (>250 Hz) occur, resembling findings from IHKA in rats and TLE patients. Pathology in the hippocampus at the site of IHKA injection was similar to mesial temporal lobe sclerosis and reduced contralaterally. In summary, our methods produce a model of TLE in mice with robust convulsive seizures, and there is variable progression. HFOs are robust also, and seizures have onset patterns and pathology like human TLE. SIGNIFICANCE: Although the IHKA model has been widely used in mice for epilepsy research, there is variation in outcomes, with many studies showing few robust seizures long-term, especially convulsive seizures. We present an implementation of the IHKA model with frequent convulsive seizures that are robust, meaning they are >10 s and associated with complex high frequency rhythmic activity recorded from 2 hippocampal and 2 cortical sites. Seizure onset patterns usually matched the low-voltage fast and hypersynchronous seizures in TLE. Importantly, there is low mortality, and both sexes can be used. We believe our results will advance the ability to use the IHKA model of TLE in mice. The results also have important implications for our understanding of HFOs, progression, and other topics of broad interest to the epilepsy research community. Finally, the results have implications for preclinical drug screening because seizure frequency increased in approximately half of the mice after a 6 wk. interval, suggesting that the typical 2 wk. period for monitoring seizure frequency is insufficient.
PMID: 35091040
ISSN: 1095-953x
CID: 5154982
Level of behavioral health integration and suicide risk screening results in pediatric ambulatory subspecialty care
Urban, Tamaki H; Stein, Cheryl R; Mournet, Annabelle M; Largen, Kelsey; Wuckovich, Michael; Lois, Becky H
OBJECTIVE:This study aimed to characterize suicide risk screening results for youth in pediatric ambulatory subspecialty clinics. METHOD/METHODS:The Ask Suicide-Screening Questions was administered to patients ages 9-24Â years in 12 subspecialty clinics to assess suicide risk, determined by suicide ideation/behavior. The SAMSHA-HRSA standard framework for integrated health was used to categorize each clinic's level of behavioral health integration. RESULTS:6365 patients completed 7440 suicide risk screens; 6.2% of patients screened positive at their initial screen and 4.1% at subsequent annual screens. There was no dose-response pattern between increasing level of integration and decreasing likelihood of a positive suicide screen. Youth identifying as gender expansive were 3.1 times (95% CI [2.0, 4.9]) more likely to screen positive as compared to cisgender youth, adjusted for age, gender, race/ethnicity, screen type, year, and clinic integration level. CONCLUSION/CONCLUSIONS:Results surrounding disparities in suicide risk based on gender identity underscore the importance of further investigating how to optimally identify and manage high-risk, often understudied youth at suicide risk.
PMID: 35101784
ISSN: 1873-7714
CID: 5153412
Behavioral coping phenotypes and associated psychosocial outcomes of pregnant and postpartum women during the COVID-19 pandemic
Werchan, Denise M; Hendrix, Cassandra L; Ablow, Jennifer C; Amstadter, Ananda B; Austin, Autumn C; Babineau, Vanessa; Anne Bogat, G; Cioffredi, Leigh-Anne; Conradt, Elisabeth; Crowell, Sheila E; Dumitriu, Dani; Fifer, William; Firestein, Morgan R; Gao, Wei; Gotlib, Ian H; Graham, Alice M; Gregory, Kimberly D; Gustafsson, Hanna C; Havens, Kathryn L; Howell, Brittany R; Humphreys, Kathryn L; King, Lucy S; Kinser, Patricia A; Krans, Elizabeth E; Lenniger, Carly; Levendosky, Alytia A; Lonstein, Joseph S; Marcus, Rachel; Monk, Catherine; Moyer, Sara; Muzik, Maria; Nuttall, Amy K; Potter, Alexandra S; Salisbury, Amy; Shuffrey, Lauren C; Smith, Beth A; Smith, Lynne; Sullivan, Elinor L; Zhou, Judy; Thomason, Moriah E; Brito, Natalie H
The impact of COVID-19-related stress on perinatal women is of heightened public health concern given the established intergenerational impact of maternal stress-exposure on infants and fetuses. There is urgent need to characterize the coping styles associated with adverse psychosocial outcomes in perinatal women during the COVID-19 pandemic to help mitigate the potential for lasting sequelae on both mothers and infants. This study uses a data-driven approach to identify the patterns of behavioral coping strategies that associate with maternal psychosocial distress during the COVID-19 pandemic in a large multicenter sample of pregnant women (N = 2876) and postpartum women (N = 1536). Data was collected from 9 states across the United States from March to October 2020. Women reported behaviors they were engaging in to manage pandemic-related stress, symptoms of depression, anxiety and global psychological distress, as well as changes in energy levels, sleep quality and stress levels. Using latent profile analysis, we identified four behavioral phenotypes of coping strategies. Critically, phenotypes with high levels of passive coping strategies (increased screen time, social media, and intake of comfort foods) were associated with elevated symptoms of depression, anxiety, and global psychological distress, as well as worsening stress and energy levels, relative to other coping phenotypes. In contrast, phenotypes with high levels of active coping strategies (social support, and self-care) were associated with greater resiliency relative to other phenotypes. The identification of these widespread coping phenotypes reveals novel behavioral patterns associated with risk and resiliency to pandemic-related stress in perinatal women. These findings may contribute to early identification of women at risk for poor long-term outcomes and indicate malleable targets for interventions aimed at mitigating lasting sequelae on women and children during the COVID-19 pandemic.
PMCID:8786860
PMID: 35075202
ISSN: 2045-2322
CID: 5153202
Sex-specific effects of prenatal undernutrition on resting-state functional connectivity in the human brain at age 68
Boots, Amber; Thomason, Moriah E; Espinoza-Heredia, Claudia; Pruitt, Patrick J; Damoiseaux, Jessica S; Roseboom, Tessa J; de Rooij, Susanne R
Prenatal nutrition may significantly impact brain aging. Results from the Dutch Famine Birth Cohort indicated that prenatal undernutrition is negatively associated with cognition, brain volumes, perfusion and structural brain aging in late life, predominantly in men. This study investigates the association between prenatal undernutrition and late-life functional brain network connectivity. In an exploratory resting-state functional magnetic resonance imaging study of 112 participants from the Dutch Famine Birth Cohort, we investigated whether the within- and between-network functional connectivity of the default mode network, salience network and central executive network differ at age 68 in men (NÂ =Â 49) and women (NÂ =Â 63) either exposed or unexposed to undernutrition in early gestation. Additionally, we explored sex-specific effects. Compared to unexposed participants, exposed participants revealed multiple clusters of different functional connectivity within and between the three networks studied. Sex-specific analyses suggested a pattern of network desegregation fitting with brain aging in men and a more diffuse pattern of group differences in women. This study demonstrates that associations between prenatal undernutrition and brain network functional connectivity extend late into life.
PMID: 35151035
ISSN: 1558-1497
CID: 5157052